News About: Pharm. Affairs
FDA begins approval procedure of the first antibody biosimilar, Celltrion’s ‘Remsima’
Through its website, the U.S. Food and Drug Administration(hereinafter referring to FDA) announced that it is expected to hold the Arthritis Advisory Committee at the FDA White Oak Campus in Maryland and discuss matte...
Golden age of domestic biopharmaceutical products, pouring foreign entries
At the beginning of the year, foreign expansion of domestic biopharmaceutical products has produced results. While technology of the anemia treatment being developed by Chong Kun Dang is exported, Samsung Bioepis acqu...
Facing entry of follow-up drugs, Tamiflu to be launched in a new formation
‘Tamiflu,’ an antiviral drug which soon will face the entry of follow-up drugs due to the expiration of its substance patent, has attracted attention of the industry with different volume types.
According to the Mini...
Despite depression of domestic market, last year’s pharmaceutical sales reached KRW 12.6 trillion
Due to the depression of the domestic market, the sales of pharmaceutical products are expected to grow 3.3% last year compared to the year before.
Shinhan Investment Corp. estimated the last year’s pharmaceutical sa...
Pharmaceutical companies, “The next target is the ‘prostatism’ market”
As a target for the next male-specific disease, pharmaceutical companies have focused on ‘prostatism.’
Prostatism, a well-known disease for the middle-aged and aged, is a disease caused as the size of prostate enlarg...
First domestically developed/manufactured oral cholera vaccine acquires WHO PQ
On the 12th, the International Vaccine Institute(IVI) and Eubiologics announced ‘Euvichol,’ an inactivated oral cholera vaccine manufactured by Eubiologics, has recently acquired the prequalification(PQ) by the World ...
Boehringer’s SGLT-2 complex, Synjardy, is expected to be approved this monthThe complex of the Boehringer Ingelheim’s SGLT-2-inhibitor antidiabetic agent, Jardiance(empagliflozin), and metformin will enter the domestic market this month at the fastest.
...
|
Supreme Court decides the patent suit of Lyrica on 14th
The final decision of the patent suit for the use patent of the Lyrica(Pfizer), a large-scale painkiller, will be made on the 14th.
The Supreme Court will announce the decision on the action of nullity of the Lyrica’...
Late entry of ‘Original’ Sanofi in the Plavix complex market
The original company has made a move. Sanofi, the developing company of ‘Plavix,’ is planning to enter the ‘aspirin’ complex market.
According to the industry concerned on the 11th, Sanofi-Aventis Korea is working on...
Domestic pharmaceutical industry expected to narrowly grow in 2016
It was expected the domestic pharmaceutical market will narrowly grow and market shares of the top companies will rally in 2016. Exportation of pharmaceutical products is anticipated to grow smoothly through the incre...
